Self-StudyCo-Occurring Conditions
Sign In or Register to get started
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 5 Overview
Hepatitis B Coinfection - 0%Topic 1
BackgroundActivities- 0%Topic 2
Screening for HBV in Persons with HIVActivities- 0%Topic 3
Initial Evaluation of Persons with HBV and HIV CoinfectionActivities- 0%Topic 4
Treatment of HBV and HIV in Persons with HIV and HBV CoinfectionActivities- 0%Topic 5
Monitoring HBV Treatment ResponseActivities- 0%Topic 6
Management of HIV or HBV Virologic FailureActivities- 0%Topic 7
Stopping HBV Treatment and Hepatic FlaresActivities- 0%Topic 8
HBV-Related Immune Reconstitution Syndrome (HBV-IRIS)Activities- 0%Topic 9
Hepatitis D VirusActivities- 0%Topic 10
Preventing HBV Perinatal TransmissionActivities- 0%Topic 11
Surveillance for Hepatocellular CarcinomaTopic 11. Surveillance for Hepatocellular Carcinoma
Sign in Required to Track Progress
To access the Topics in this Lesson, you must Sign In or Register Required for CNE/CME
Signing in will track your progress and allow you to claim CE credits.
No sign-in for Quick Reference Views
You can find all of the topics from this module in the openly accessible
Quick ReferenceFunded byHealth Resources and Services Administration (HRSA)Created at University of WashingtonAn AETC ProgramPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE approved byOregon Nurses AssociationCopyright © 2025 National HIV CurriculumThe Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,994. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-d52d2330-2025-09-05-201745 - 0%Topic 2
Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine Edurant